Bavarian Nordic A/S – Registration of Share Capital Increase of 5,150,000 New Shares Completed

On March 12, 2021 Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) ("Bavarian Nordic" or the "Company") reported it has in connection with the directed issue and private placement registered with the Danish Business Authority, a capital increase of a nominal value of DKK 51,500,000 (5,150,000 shares of DKK 10 each) (the "New Shares"), representing 8.81 % of the registered share capital prior to the capital increase (the "Offering") (Press release, Bavarian Nordic, MAR 12, 2021, View Source [SID1234576591]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The New Shares have been issued under a temporary ISIN code and are expected to be admitted to trading and official listing under the permanent ISIN code DK0015998017 on Nasdaq Copenhagen A/S with effect from 15 March 2021.

After registration of the share capital increase, the share capital of Bavarian Nordic amounts to nominally DKK 636,001,120 divided into 63,600,112 shares of DKK 10 each. The total number of voting rights in Bavarian Nordic are 63,600,112.

The New Shares rank pari passu with the Company’s existing shares and carry the same dividend and other rights. Each New Share carries one vote at the Company’s general meetings.

Reference is made to company announcements no. 4 and 5 of 9 and 10 March 2021.

The amendments to the Company’s articles of association required by the capital increase have been registered today with the Danish Business Authority and an updated version can be found at bavarian-nordic.com.

MANAGERS
Danske Bank A/S, Jefferies International Limited, Jefferies GmbH and Nordea Danmark, filial af Nordea Bank Abp, Finland are acting as Joint Global Coordinators and Joint Bookrunners (together the "Joint Global Coordinators" and "Joint Bookrunners") in connection with the Offering. Nordea Danmark, filial af Nordea Bank Abp, Finland acts as settlement agent for the Offering.

Kromann Reumert and Latham & Watkins LLP act as Danish and U.S. legal advisors respectively to the Company. Plesner acts as Danish legal advisors to the Joint Global Coordinators and Joint Bookrunners.